Risk of Violations in Advertising Representations
First written in FY2025. 1 of 2 entries say "Mitigated", first in FY2026. Latest entry: FY2026.
2 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Specifically, various laws and regulations impose certain restrictions, including the Act against Unjustifiable Premiums and Misleading Representations and the Pharmaceuticals and Medical Devices Act. With the involvement of attorneys specializing in the Pharmaceuticals and Medical Devices Act and the Act against Unjustifiable Premiums and Misleading Representations, the company reviews the checklist as necessary and eliminates the associated risks.」
In addition to reviews by multiple people, the disclosure specifically states that specialist attorneys are involved and that the checklist is reviewed. - FY2025First statedAnnual report
「For all advertising representations, the company conducts advertising reviews by multiple people using an “Advertising Creative Checklist” and works to ensure legal compliance and maintain public order and standards of decency through thorough implementation of the review process.」
The disclosure describes the risk that advertising representations may violate laws and regulations, while noting reviews by multiple people, use of a checklist and review by specialist attorneys.